Access the latest issue of Nutraceuticals World and browse our extensive archives to catch up on past articles and features.
Read the full digital edition of Nutraceuticals World, complete with interactive content and enhanced features for an engaging experience.
Join our community! Subscribe to Nutraceuticals World to receive the latest industry news, insights, and updates directly to your mailbox.
Learn about Nutraceuticals World’s mission, vision, and commitment to providing valuable information and resources for the nutraceutical industry.
Discover advertising opportunities with Nutraceuticals World to connect with a targeted audience in the nutraceutical sector.
Review our editorial guidelines for contributions and submissions to ensure your content aligns with our standards.
Read about our commitment to protecting your privacy and how we handle your personal information.
Familiarize yourself with the terms and conditions governing the use of nutraceuticalsworld.com.
Dive into feature articles that provide in-depth analysis and discussions on critical topics within the nutraceutical space.
Access unique content and exclusive interviews with industry leaders and innovators, offering insights into the future of nutraceuticals.
Discover the top companies in the nutraceutical industry, highlighting their innovations and contributions to the market.
Gain valuable perspectives from suppliers on market trends, challenges, and opportunities within the nutraceutical sector.
Stay informed with regular market updates that track the latest trends and developments impacting the nutraceutical industry.
Explore mergers and acquisitions, financial performance, and investment trends shaping the nutraceutical landscape.
Learn about the latest innovations in manufacturing and formulation processes that enhance product quality and efficacy.
Discover new products and ingredients making waves in the nutraceutical market, along with their benefits and applications.
Stay updated on regulatory developments and compliance issues affecting the nutraceutical industry.
Access the latest research findings and studies that inform trends and innovations in nutraceuticals.
Learn about nutraceutical products that support beauty and wellness, focusing on ingredients that address age-related concerns.
Discover nutraceutical solutions aimed at supporting bone, joint, and muscle health for optimal mobility.
Stay informed on products and ingredients promoting cardiovascular health and wellbeing.
Explore nutraceutical options designed to support the health and development of children.
Learn about nutraceutical products that enhance cognitive function and mental clarity.
Discover nutraceutical solutions that boost energy levels and support overall vitality.
Stay updated on ingredients and products promoting eye health and vision wellness.
Explore nutraceutical offerings tailored specifically for men’s health and wellness.
Learn about nutraceuticals that promote relaxation, stress relief, and improved sleep quality.
Stay informed about antioxidant-rich ingredients that combat oxidative stress and promote overall health.
Explore the benefits of green ingredients, including superfoods and their roles in health and wellness.
Learn about the uses and benefits of herbs, botanicals, and mushrooms in the nutraceutical sector.
Discover the health benefits of omega-3s and other nutritional oils for overall wellbeing.
Stay updated on the latest research and products related to probiotics and prebiotics.
Explore the role of protein and fiber in nutrition and their importance in dietary supplements.
Learn about alternative sweeteners and their applications in the nutraceutical market.
Discover essential vitamins and minerals that support health and wellbeing in various products.
Access our buyer’s guide to find trusted suppliers and service providers in the nutraceutical market.
Identify the top companies leading the nutraceutical industry with innovative products and solutions.
Explore the capabilities of leading nutraceutical companies and their areas of expertise.
Familiarize yourself with key terms and definitions related to the nutraceutical industry.
Watch informative videos featuring industry experts discussing trends, innovations, and insights in nutraceuticals.
Enjoy short, engaging videos that provide quick insights and updates on key nutraceutical topics.
Tune in to discussions with industry leaders sharing their perspectives on trends and challenges in the nutraceutical sector.
Access comprehensive eBooks covering various topics in nutraceuticals, from formulation to marketing.
Read in-depth whitepapers that examine key issues, trends, and research findings in the nutraceutical industry.
Explore informational brochures that provide insights into specific products, companies, and market trends.
Access sponsored articles and insights from leading companies in the nutraceutical sector.
Stay informed with the latest news releases and announcements from companies in the nutraceutical industry.
Browse job opportunities in the nutraceutical sector, connecting you with potential employers.
Discover major industry events, trade shows, and conferences focused on nutraceuticals and dietary supplements.
Participate in informative webinars led by industry experts, covering various topics in nutraceuticals.
Discover exclusive live streams and updates from the hottest events and shows.
What are you searching for?
It appears the relationship between these two markets may not be as adversarial as it was in years past.
September 9, 2013
By: Gregory Stephens
I have heard more than a few comments lately about a convergence of the pharmaceutical and dietary supplement industries. The notion that, once again, “Big Pharma” and consumer packaged goods (CPG) companies are buying their way into the supplement space was echoed repeatedly at the recent NBJ Summit. Pharmaceutical Acquisitions in the 1990s Recent acquisition activity is reminiscent of the late 1990s, when both pharmaceutical and CPG companies began making a big run at the rapidly growing dietary supplement industry. Solgar’s acquisition by American Home Products (which was later purchased by Wyeth, which was subsequently bought by Pfizer) was a pivotal deal that seemed to set off a spending spree. During this period of acquisition activity, Warner-Lambert launched its line of supplements, Quanterra, which was followed by similar lines branded by Centrum and Bayer. CPG companies were not to be left behind. P&G launched OLAY supplements for women; Nestle bought PowerBar and in 2000 Kraft bought Balance Bar. The driving force for many of these companies was the decline of top-line sales in their core businesses. The strategy of moving into dietary supplements was intended to leverage the parent company’s core competencies to drive sales and improve margins. Primarily, these large companies offered increased distribution into FDMC (food/drug/mass market/club stores), brand marketing supported by hefty promotional budgets, product innovation through R&D muscle and the assurance of quality and safety that consumers entering the category were seeking. Following most of these acquisitions, the current management was left in place and provided the support needed for growth and increased profitability. Of course, this was the case until quarterly earnings were missed the first time. Then the supplement company received a wealth of “assistance” from the corporate team. After management changes and reduction of staffing redundancies were implemented, profits were back on track—for the short-term. In the end, the low hanging fruit proved to be just out of reach. Some suggested these companies were a little ahead of their time—a comment recently echoed by P&G regarding the OLAY supplement launch; many didn’t seem to understand the market and others appeared just arrogant in their approach. Ten years after acquiring Balance Bar, Kraft divested the business for one-fifth of what it paid originally. In the end, it seemed that the only beneficiary of these ventures were companies like NBTY, which was able to snap up some business opportunities it could leverage at slightly higher than liquidation prices. Renewed Interest in Supplements So here we are again, a generation of marketers later. Drug pipelines are running dry and Big Pharma is once again aggressively moving into the dietary supplement space. P&G acquired New Chapter and Pfizer acquired Alacer Corp., the maker of Emergen-C. The British consumer company Reckitt Benckiser topped Bayer in a bidding war for Schiff Nutrition. The major ingredient suppliers are not to be left behind. DSM and BASF acquired Ocean Nutrition and Pronova BioPharma, respectively. Looking beyond the U.S. dietary supplement market, Pfizer bought Ferrosan Consumer Health, a Danish company that markets supplements in the emerging markets of Russia and Eastern Europe. Today’s supplement market is considerably different than it was 10-15 years ago. The supplement consumer base has grown to reflect more mainstream behaviors and attitudes. For example, Baby Boomers represent a more mature consumer seeking products to defend against age-related health issues. Also, physicians and other health practitioners are more willing to recommend and even dispense supplements to their patients. Is the Shoe on the Other Foot? This brings us to another interesting dynamic in the pharmaceutical–supplement dance. Pharmaceutical companies are noticing the dietary supplement industry is encroaching on one of their sacred markets: Medical Foods. Medical food is not the small niche market many perceive it to be. Globally, it is estimated to be a $9 billion market; the U.S. has surpassed $2 billion. Traditionally a conservative, fairly slow-moving market, the pace of innovation is exploding. The global market is now seeing more than 100 new product launches annually, according to Innova Market Insights (2011). Driven by increasing consumer interest in personalized healthcare and the rapidly growing Boomer population, medical foods are expected to continue realizing double-digit growth for the foreseeable future. What is spurring interest in medical foods among supplement companies? One reason is a fundamental regulatory difference between dietary supplements and medical foods. Basically, supplements are intended for healthy individuals and medical foods are for the dietary management of diseases. This translates to mean that the name of the disease being managed by medical foods must actually be included on the product label. This is significantly different from structure-function claims on which supplements often rely. With more FDA Warning Letters issued to companies making claims on what are considered disease biomarkers (e.g., inflammation), medical food claims offer a new avenue to communicate benefits to consumers and healthcare professionals. The opportunity is even more attractive when one considers that FDA requires no premarket approval for medical foods. This is not to suggest that the medical foods market is unregulated. Rather, as recently addressed by our esteemed panel of regulatory attorneys on our medical foods panel at the NBJ Summit, there are significant regulatory requirements for this class of foods (“Unraveling the Medical Foods and Clinical Nutrition Opportunity,” NBJ Summit, Jul. 25, 2013). Though many recent products appear to be “flying under the FDA radar,” aggressive action by the agency is expected for less responsible companies. Reflecting on the traditional dietary supplement channels, there is a significant opportunity for medical foods in the rapidly growing health practitioner segment. Supported by the regulatory requirements that medical foods be used under the supervision of a qualified health professional, this is a viable strategic approach. (For more information, refer to information on the 2014 Health Practitioner Marketing Forum at the end of this article.) Finding Common Ground Innovation in the U.S. medical food market has not come through organic growth from the major pharmaceutical companies. More so than in the past, these companies are looking outside for acquisitions and licensing opportunities to fuel growth. Nestle’s acquisition of Pamlab earlier this year is a representative example. Pamlab’s portfolio of medical food products targeting the nutritional management of patients with mild cognitive impairment, depression and diabetic peripheral neuropathy are ideal for the emerging trend of personalized healthcare and the aging population. Similarly, Nestle’s stake in Accera, maker of Axona, a medical food providing nutritional management for Alzheimer’s patients supports this strategy. Beyond the regulatory experts on the medical food panel I moderated at the NBJ Summit, our panel included executives from pharmaceutical and practitioner focused companies. Dr. Robert Miller, PhD, vice president of R&D and innovation for Abbott Nutrition shared his company’s interest in Open Innovation and partnering with smaller companies with novel nutritional technologies. Abbott is actively seeking partners that bring strong science and quality products addressing the nutritional needs of their targeted indications. It appears the convergence of the two markets, pharmaceuticals and dietary supplements, are not as adversarial as in years past. Many are seeing the interest in their markets by outside companies as more of an opportunity than a threat. Successful companies today see the need to partner and work together toward the common goal of nutrition to maintain health and wellness, as well as to help manage nutritional needs of people with diseases. After all, this is what brought most of us into the nutrition industry.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !